Puts Purchased on Cubist Pharmaceuticals, Inc.

Shares of Cubist Pharmaceuticals, Inc.

are higher on the session by 0.59%, currently trading at $35.89. The stock has been moving largely higher over the past six months and is currently trading above the 200-day moving average. Options traders are buying puts on the name today. Though action has been primarily in small lots, overall put volume is now running at 2.59x the daily average with 94% of all puts traded being purchases on the offer. Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.